The study focused on patients with lung and skin cancers. Show Quick Read Summary is AI Generated. Newsroom Reviewed

A new study suggests that cancer patients who received a Covid-19 mRNA vaccine within 100 days of starting immunotherapy lived significantly longer than those who did not. Researchers from the University of Florida (UF) and MD Anderson Cancer Center believe the vaccine may trigger immune responses that boost the effectiveness of cancer treatments.

The research focused on patients with advanced lung and skin cancers. Those vaccinated within 100 days of beginning immunotherapy experienced longer survival, according to data from over 1,000 MD Anderson patients.

Scientists describe the vaccine as acting like a nonspecific “flare” that reactivates the immune system, poten

See Full Page